CasLoc logo
All Cases PTAB Litigations UPC Oppositions

BioDelivery Sciences International, Inc. v. Actavis Laboratories UT, Inc.

1:16-cv-00175

Overview

Case Number 1:16-cv-00175
Filing Date 2016-03-18
Status Terminated
Termination Date 2017-10-13
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Actavis Laboratories UT, Inc. Operating Company

Represented By

7 Attorneys Listed

James L. Higgins

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-5034

Rodney Square, 1000 North King Street

Robert M. Vrana

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6600

Rodney Square, 1000 North King Street

Michael K. Nutter

Email: mnutter@mcguirewoods.com

Shilpa A. Coorg

Email: scoorg@winston.com

Melanie K. Sharp

Young, Conaway, Stargatt & Taylor LLP

Tel: +1 (302) 571-6681
Fax: +1 (302) 571-1253

Rodney Square, 1000 North King Street

David P. Dalke

Email: ddalke@winston.com

Tyler G. Johannes

UNDELIVERABLE EMAIL 8/20/2019

Actavis, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Arius Two, Inc. Operating Company

Represented By

3 Attorneys Listed

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Emily Gabranski

Email: emily.gabranski@finnegan.com

BioDelivery Sciences International, Inc. Operating Company

Represented By

10 Attorneys Listed

Thomas J. Sullivan

Email: thomas.sullivan@finnegan.com

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Charles E. Lipsey

Email: charles.lipsey@finnegan.com

Jonathan R. Davies

Email: jdavies@cooley.com

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Howard W. Levine

Email: howard.levine@dechert.com

Jennifer S. Swan

Email: jennifer.swan@dechert.com

Emily Gabranski

Email: emily.gabranski@finnegan.com

Courtney B. Casp

Email: courtney.casp@finnegan.com

Jeffrey D. Smyth

Email: jeffrey.smyth@finnegan.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 2 proceedings
🏛️
USPTO PTAB Trials 1 proceeding
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): 🇺🇸 US 🌐 PCT
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 1 U.S. Courts: 2
USPTO PTAB Trial 2014-01-22
IPR2014-00376

MONOSOL RX, LLC v. Arius Two, Inc. et al.

Asserted Patent
Status: Final Written Decision
U.S. District Court 2017-03-16
1:17-cv-00282

BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA, Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-12-22
1:16-cv-01303

BioDelivery Sciences International, Inc. v. Teva Pharmaceuticals USA Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7579019
Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
Filed: 2005-03-01
Issued: 2009-08-25
Expired (Term Ended)
Expires: 2021-01-19
US8147866
Transmucosal delivery devices with enhanced uptake
Filed: 2011-07-15
Issued: 2012-04-03
Active (4.6 yrs remaining)
Expires: 2031-07-15
US8703177
Abuse-resistant mucoadhesive devices for delivery of buprenorphine
Filed: 2012-08-20
Issued: 2014-04-22
Active (5.7 yrs remaining)
Expires: 2032-08-20
US9522188
Abuse resistant transmucosal drug delivery device
Filed: 2006-12-13
Issued: 2016-12-20
Active (8.4 yrs remaining) +3054d PTA
Expires: 2035-04-24

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

38

Dispositive

0

Granted

0

Denied

0

Pending / Review

24

Motions by Category

Claim Construction / Markman Filing 15 Procedural / Extension Motion 23

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
CLAIM Construction Chart by Actavis Laboratories UT, Inc.. (Higgins, James) (Entered: 06/01/2017)
Entry #117 • 2017-06-01 Document →
Claim Construction / Markman Filing Pending / Under Review
ORDER Setting Teleconference: Defense counsel to initiate the call. A Telephone Conference is set for 9/14/2017 at 11:00 AM Eastern Time before Judge Mary Pat T...
Entry #90 • 2017-04-04 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for plaintiffs to file an Amended Complaint and for defendants to file its answer to the Amended Complaint to March 8, 2017 and March...
Entry #82 • 2017-03-06 Document →
Procedural / Extension Motion Pending
SO ORDERED - re 81 Joint STIPULATION TO EXTEND TIME for Plaintiffs to file and Amended Complaint to March 6, 2017 filed by Actavis Laboratories UT, Inc., 82 STI...
Entry #— • 2017-03-06
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME for Plaintiffs to file and Amended Complaint to March 6, 2017 - filed by Actavis Laboratories UT, Inc.. (Higgins, James) (Enter...
Entry #81 • 2017-03-03 Document →
Claim Construction / Markman Filing Pending
SO ORDERED - re Letter and Stipulation ( 80 ): (Fact Discovery completed by 6/1/2017., Opening Expert Reports due by 6/30/2017., Rebuttal Expert Reports due by ...
Entry #— • 2017-02-21

Docket Entries

(220 total)
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories UT, Inc., Actavis, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1897907.) - filed by BioDelivery Sciences International, Inc., Arius Two, Inc.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(sec) (Entered: 03/18/2016)

Entry #1 • 2016-03-18
1
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories UT, Inc., Actavis, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1897907.) - filed by BioDelivery Sciences International, Inc., Arius Two, Inc.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(sec) (Entered: 03/18/2016)

Entry #1 • 2016-03-18
2
Pleading / Complaint

COMPLAINT for PATENT INFRINGEMENT filed against Actavis Laboratories UT, Inc., Actavis, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1897907.) - filed by BioDelivery Sciences International, Inc., Arius Two, Inc.. (Attachments: # 1 Exhibit A-C, # 2 Civil Cover Sheet)(sec) (Entered: 03/18/2016)

Entry #1 • 2016-03-18
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sec) (Entered: 03/18/2016)

Entry #2 • 2016-03-18
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/05/2016. Date of Expiration of Patent: SEE ANDA.Thirty Month Stay Deadline: 8/5/2018. (sec) (Entered: 03/18/2016)

Entry #3 • 2016-03-18
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc